Regulation of matrixmetalloproteinase-3 and matrixmetalloproteinase-13 by SUMO-2/3 through the transcription factor NF-κB

Annals of the Rheumatic Diseases

Volumn 72, Issue 11, 2013, Pages 1874-1881

  Frank, Svetlana ^a   Peters, Marvin A ^a   Wehmeyer, Corinna ^a   Strietholt, Simon ^a   Koers Wunrau, Christina ^a   Bertrand, Jessica ^a   Heitzmann, Marianne ^a   Hillmann, Anja ^a   Sherwood, Joanna ^a   Seyfert, Christine ^b   Gay, Steffen ^c   Pap, Thomas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Zeisigwaldkliniken ^*  (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SMALL INTERFERING RNA; STROMELYSIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; ENZYME SYNTHESIS; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM;

FIBROBLASTS; RHEUMATOID ARTHRITIS; TNF-ALPHA;

ANIMALS; ARTHRITIS, RHEUMATOID; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MICE; MICE, TRANSGENIC; NF-KAPPA B; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINS;

EID: 84885186818     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202080     Document Type: Article

References (30)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Pap T, Muller-Ladner U, Gay RE, et al. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000;2:361-7.
3. Muller-Ladner U, Pap T, Gay RE, et al. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005;1:102-10.
4. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28(6 Pt 2):500-10.
5. Fabunmi RP, Baker AH, Murray EJ, et al. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1,-2, and-3 in rabbit aortic smooth muscle cells. Biochem J 1996;315(Pt 1):335-42.
6. Li X, Luo Y, Yu L, et al. SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis. Cell Death Differ 2008;15:739-50.
7. Huang TT, Wuerzberger-Davis SM, Wu ZH, et al. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003;115:565-76.
8. Arco P Gomez-del, Koipally J, Georgopoulos K. Ikaros SUMOylation: switching out of repression. Mol Cell Biol 2005;25:2688-97.
9. Chang CC, Lin DY, Fang HI, switching out of repression. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J Biol Chem 2005;280:10164-73.
10. Hay RT. Protein modification by SUMO. Trends Biochem Sci 2001;26:332-3.
11. Chen L, Chen J. MDM2-ARF complex regulates p53 sumoylation. Oncogene 2003;22:5348-57.
12. Meinecke I, Cinski A, Baier A, et al. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc Natl Acad Sci USA 2007;104:5073-8.
13. Kamitani T, Kito K, Nguyen HP, et al. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem 1998;273:11349-53.
14. Tatham MH, Jaffray E, Vaughan OA, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 2001;276:35368-74.
15. Matic I, van Hagen M, Schimmel J, et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics 2008;7:132-44.
16. Tatham MH, Geoffroy MC, Shen L, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 2008;10:538-46.
17. Schimmel J, Larsen KM, Matic I, et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics 2008;7:2107-22.
18. Matic I, Macek B, Hilger M, et al. Phosphorylation of SUMO-1 occurs in vivo and is conserved through evolution. J Proteome Res 2008;7:4050-7.
19. Maciejewska-Rodrigues H, Karouzakis E, Strietholt S, et al. Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression. J Autoimmun 2010;35:15-22.
20. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-69.
21. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
22. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998;2:233-9.
23. Franz JK, Pap T, Hummel KM, et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 2000;43:599-607.
24. Liacini A, Sylvester J, Li WQ, et al. Inhibition of interleukin-1- stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002;21:251-62.
25. Liacini A, Sylvester J, Li WQ, et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 2003;288:208-17.
26. Bond M, Chase AJ, Baker AH, et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50:556-65.
27. Kim EM, Lee HH, Kim SH, et al. The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFkappaB into the nucleus. Mol Immunol 2011;48:2189-97.
28. Bae SH, Jeong JW, Park JA, et al. Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem Biophys Res Commun 2004;324:394-400.
29. Ahn JK, Koh EM, Cha HS, et al. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 2008;47:834-9.
30. Berta MA, Mazure N, Hattab M, et al. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity. Biochem Biophys Res Commun 2007;360:646-52.